Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE224813 |
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia [CUT&TAG]
|
4 | Xaingyu Pan | Apr 23, 2024 | ||||
GSE224816 |
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia
|
|
22 | Xaingyu Pan | Apr 23, 2024 | |||
GSE142645 |
Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression
|
|
195 | Xaingyu Pan | Jan 30, 2023 | |||
GSE147526 |
A Zebrafish-Based Orthotopic Glioblastoma Xenograft Model for Preclinical Drug Screening and Clinical Drug Sensitivity Prediction
|
|
34 | Xaingyu Pan | Apr 12, 2022 | |||
GSE192575 |
Acquired semi-squamalization during chemotherapy suggests a differentiation therapy for bladder cancer
|
|
42 | Xaingyu Pan | Jul 09, 2022 | |||
GSE224106 |
Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug
|
6 | Xaingyu Pan | Sep 13, 2023 | ||||
GSE224815 |
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia [RNA-seq]
|
12 | Xaingyu Pan | Apr 23, 2024 | ||||
GSE239350 |
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia [RNA-seq 2]
|
|
6 | Xaingyu Pan | Apr 23, 2024 | |||
GSE138504 |
Nivolumab treatment for relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistocytosis in adults
|
4 | Xaingyu Pan | Oct 07, 2019 | ||||
GSE218137 |
The role of DNMT3A in AITL
|
|
3 | Xaingyu Pan | Aug 13, 2023 | |||
GSE188900 |
The confused cell identity is associated with aggressiveness in esophageal squamous cell carcinoma [scRNA-Seq]
|
8 | Xaingyu Pan | Mar 16, 2022 | ||||
GSE188955 |
The confused cell identity is associated with aggressiveness in esophageal squamous cell carcinoma
|
|
20 | Xaingyu Pan | Mar 16, 2022 |